News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Grants (World)
Imaxio Release: France’s National Research Agency Selects The OPTIVAC Project And Contributes €600,000 ($772,000) To Improve The Efficacy Of Influenza Vaccines 10/27/2014
Evotec AG (EVTG.F) And Its Partners Awarded Public Grants To Develop New Drug Candidates To Treat Multiple Sclerosis 9/24/2014
EFIC-Grünenthal Grant: Supporting Up-And-Coming Researchers In The Field Of Pain 9/23/2014
Helsinn To Provide Independent Educational Grant Support For A Satellite Symposium On Delivering Chemotherapy With Confidence: New Strategies To Minimize Treatment-Induced Nausea And Vomiting At The 38th European Society For Medical Oncology (ESMO) Congress 9/22/2014
Beta-O2 Receives Grant From JDRF To Advance Clinical Development Of The ßair Bio-Artificial Pancreas As A Potential Cure For Type 1 Diabetes 9/10/2014
Ablynx (ABLYF) Awarded EU2.1 Million Grant To Support Development Of Novel Nanobodies® For Ocular Applications 8/13/2014
Clinical Study With BioTie Therapies Corp.''s BTT1023 In Primary Sclerosing Cholangitis Awarded External Grant Funding 7/24/2014
BioTie Therapies Corp. Awarded $2 Million Grant From The Michael J. Fox Foundation For A Clinical Study With SYN120 In Parkinson's Disease Dementia 7/8/2014
Phico Therapeutics Awarded Technology Strategy Board Biomedical Catalyst Grant To Develop Its SASPject Antibiotic Technology For Drug Resistant Bacteria 7/7/2014
EMD Serono Commits EUR 2 Million To The Grant For Fertility Innovation (Gfi) For 2014 /15 7/1/2014
Karo Bio AB Granted 3.8 Msek From Vinnova 7/1/2014
EastGate Acquisitions Corporation Receives Research Grant From Ontario Brain Institute 6/25/2014
MediGene AG (MDGEF.PK): Trianta Receives BMBF (Federal Ministry Of Education And Research) Grant For Tabs Immunotherapy As Part Of The "M4 Leading-Edge Cluster Initiative" 6/5/2014
Northern Ireland Manufacturing Firm Wins $1.5 Million Export Contract With World's Largest Pharma-Company, Pfizer Inc. (PFE) 6/4/2014
H. Lundbeck A/S (LUN.CO) Receives Grant From The The Michael J. Fox Foundation For Biological Markers Identification In Parkinson’s Disease 5/5/2014
Plandai Biotechnology, Inc. (PLPL.OB) Up For $2.5 Million Grant In Continued Support From South African Government 5/2/2014
Pluristem Therapeutics (PSTI) Awarded $4.2 Million Grant By Israeli Government 4/30/2014
Sinovac Biotech Ltd. (SVA) Receives Notification Of China Government Grant For EV71 Vaccine Project 4/24/2014
Adaptimmune Ltd. Announces Award Of £2.1 Million From The Biomedical Catalyst Fund 3/25/2014
National Health Service Awards Significant Cytogenetics Tender To Oxford Gene Technology Ltd. 2/4/2014
Galapagos NV (GLPG.BR) Receives EU2.3 Million IWT Grant For Fibrosis Research 2/3/2014
Galapagos NV (GLPG.BR) Receives EU2.9 Million IWT Grant For Cystic Fibrosis Research 1/13/2014
Scancell: Nottingham Technology Grant 1/6/2014
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.7 Million Grant From Israel’s Office Of The Chief Scientist 12/23/2013
Bone Therapeutics And Partners Awarded Highly Competitive €3.8 Million Marie Curie Research Grant 12/17/2013
Genovis Was Granted SEK 1 Million In Research Support From VINNOVA 12/11/2013
BrainStorm Cell Therapeutics Inc. Receives $800,000 Non-Dilutive Grant From Israel’s Office Of The Chief Scientist 12/11/2013
ProSensa Holding N.V. (RNA) And Partners Awarded Second European Consortium FP7 Research Grant 11/25/2013
MiRacle Consortium Led by InteRNA Technologies and VU University Medical Center Along With Quiet Therapeutics Receives a €1.2 Million FP7 Grant From the European Union 11/4/2013
Ablynx (ABLYF) Announces Update on Anti-RSV Nanobody Programme and Receives Grant Funding for Further Development 10/31/2013
SEEK Awarded FP7 Grant to Fund Phase IIb Trial of Universal Flu Immunotherapeutic 10/15/2013
Lundbeck Inc. (LUN.CO) Research Projects Secure Funding From The Michael J. Fox Foundation 10/14/2013
EffRx Receives Prestigious EUR 5.9 Million FP7 Research Grant for the Development of EX404 for Polycystic Ovary Syndrome (PCOS) in Paediatric Populations 10/1/2013
Bio-Images Research Ltd. Partners Oxthera in "Elimox", the £1.9 Million Project in Primary Hyperoxaluria Drug Development 9/25/2013
EpimiRNA Consortium Receives €11.5 Million Funding by EU to Uncover the Effects of microRNA in Epilepsy 9/18/2013
Canbex Therapeutics Secures TSB Biocatalyst Grant 9/6/2013
Parkinson's UK Awards GBP 150,000 to Study PRANA Biotechnology (PRAN)'s PBT434 9/4/2013
Scancell DNA ImmunoBody® Patent Granted in First Market 9/3/2013
Desktop Genetics Ltd Receives £375,000 Funding to Commercialize Genetic Engineering Platform AutoClone™ 8/27/2013
Arachos Pharma Awarded Biomedical Catalyst Grant to Develop New Anti-Inflammatory Medicine 8/13/2013
Cyclacel Pharmaceuticals, Inc. (CYCC)''s Seliciclib to be Evaluated in Investigator-Initiated Clinical Study to Treat Rheumatoid Arthritis 8/13/2013
Rosetta Genomics Ltd. (ROSG) and RAMOT at Tel Aviv Sourasky Medical Center Awarded Grant From Israeli Office of the Chief Scientist to Support Development of microRNA Oncology Therapeutics 8/8/2013
Telormedix Receives EU Funding for the Development of a New Treatment for Psoriasis 8/7/2013
Pluristem Therapeutics (PSTI) Awarded a $3.3 Million Grant by Israeli Government 8/6/2013
iQur Ltd and the Edward Jenner Institute for Vaccine Research Receive Technology Strategy Board Biocatalyst Fund Grant to Develop a Novel Malaria Vaccine 8/5/2013
ProSensa B.V. Awarded EUR 6 Million EU FP7 Research Grant 8/1/2013
Summit Corporation Awarded £2.4 Million From the UK Biomedical Catalyst Fund to Support the Development of DMD Therapy 7/31/2013
NC3Rs Release: £4.8 Million Funding Awarded for Smart Approaches to Reduce Animal Use in Science 7/31/2013
iQur Ltd Leads Major European Project to Develop a Universal Influenza Virus Vaccine 7/31/2013
Mesoblast Limited Receives $4.3 Million From Australian Government for Adult Stem Cell Pipeline Development 7/18/2013
Boehringer Ingelheim Corporation and EFSD Announce First Recipients of Diabetes Research Funding 7/17/2013
BioAlliance Pharma Expands and Strengthens Its Industrial Property Assets With Two Patent Grants 7/10/2013
Cellectricon Launches Grant to Fund Electroporation-Based Research 7/10/2013
ARC Linkage Grant to Support Patrys Limited (PAB.AX)' Partnership With Macquarie University for Development of Cancer Diagnostics 7/10/2013
Auxogyn, Inc. Wins Prestigious Grant for Fertility Innovation 7/8/2013
Galapagos NV (GLPG.BR) Receives EUR 2.4 Million IWT Grant for Psoriasis Research 7/8/2013
SYGNIS Pharma AG Secures Further Financial Resources With New Investors Loan 7/8/2013
BioFocus DPI, in Collaboration With the University College London Institute of Neurology, Receives Rapid Response Innovation Award From The Michael J. Fox Foundation 6/25/2013
Lophius Biosciences GmbH Joins NEU² and Receives Substantial Grant Funding for the Diagnosis and Monitoring of Multiple Sclerosis 6/19/2013
Karolinska Development AB: EU Grants EUR 6 Million to the Clinical Development of Athera Biotechnologies' Cardiovascular Disease Antibody Therapy 6/17/2013
EU Grants EUR 6M to the Clinical Development of Athera Biotechnologies's Cardiovascular Disease Antibody Therapy 6/17/2013
BrainStorm Cell Therapeutics Inc. Receives 1.2 Million NIS Grant From Israel's Office of the Chief Scientist 6/4/2013
Atopix Awarded Biomedical Catalyst Grant to Study an Innovative Anti-Allergic Approach to the Treatment of Atopic Dermatitis 5/29/2013
SUPPRESTEM Consortium Led by Merus Receives $7.7 Million FP7 Grant From the European Union 5/28/2013
ProQinase GmbH and Mercachem Holding B.V. Obtain $3.2 Million EU EUROSTARS Grant to Establish Epigenetics Drug Discovery Platform 5/13/2013
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist 5/13/2013
Li Ka-Shing Donates $31 Million to Medical Research Institute at Oxford University 5/6/2013
Prima Biomed (PRR.AX) Release: 3.8 Million Euro Grant to Support CVAC™ Development; Prima Moving Forward With Pilot Trials of CVAC in Additional Cancer Indications 3/20/2013
Abcam plc (ABC.L) Donates an Additional £45,000 to Local Charities 3/18/2013
Prokarium Receives £0.4 Million Grant to Develop Next Generation Vaccines 3/11/2013
Apceth GmbH Received the Second Round of Funding for Its Innovative Stem Cell-Based Cancer Therapeutic as Part of the m4 Initiative of the Munich Biotech Cluster 2/4/2013
Allenex AB Receives Part of €2.6M EU Grant in Collaboration With EUROSTAM 2/1/2013
Galapagos NV (GLPG.BR) Receives $3.3 Million IWT Grant for IBD Research 1/30/2013
Boehringer Ingelheim Corporation and the EFSD Call for Grant Applications in Diabetes Research 1/17/2013
DBV Technologies and INRA Receive Funding to Develop Pediatric Bronchiolitis ("RSV") Vaccine: RSV-NanoViaSkin 1/15/2013
Galapagos NV (GLPG.BR) Receives $3.5 Million IWT Grant for Antibacterial Research 1/10/2013
Allied Healthcare Group Release: NHMRC Grant for Ian Frazer's Work on Next-GEN HPV 12/20/2012
SK Bio-Pharmaceuticals Drug Program is Granted Funding Support From Korean Government 12/13/2012
Curie-Cancer Funds Its First Selection of Five Late-Stage Projects 12/12/2012
BrainStorm Cell Therapeutics Inc. Receives 3 Million NIS Grant From Israel’s Office of the Chief Scientist 12/12/2012
CLC bio Part of $7.8 Million EU STATegra Grant to Develop Integral Analysis Platform for Epigenetics 12/12/2012
Isogenica Limited Secure Funding From UK's Technology Strategy Board to Develop Gene Library Synthesis Technology 11/29/2012
Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine 11/12/2012
MRC Technology Awarded £577,000 Through Biomedical Catalyst Funding 11/12/2012
IXICO and PsiOxus Therapeutics Limited Win Significant Funding From Government-Backed Biomedical Catalyst 11/5/2012
Glide Pharma Announces £2.3 Million ($3.7 Million) Award From UK Biomedical Catalyst for Development of Osteoporosis Treatment 11/5/2012
UK Government Awards £1.7 Million Grant to PsiOxus Therapeutics Limited for Second Phase I/II Clinical Trial of Cancer Vaccine 11/5/2012
Cyclacel Pharmaceuticals, Inc. (CYCC) Receives $1.9 Million Translational Medicine Grant Award From the UK Biomedical Catalyst to Advance Its CYC065 Targeted Drug for Leukemias 11/5/2012
ElexoPharm GmbH Receives EuroTransBio (ETB) Grant for Tumor Vessel Targeting Program 10/17/2012
NovImmune SA Release: European Commission Awards a EUR 6 Million FP7 Grant to Support Clinical Development of NI-0501 to FIGHT HLH 10/15/2012
Trophos Program Boosted by EUR 1 Million Grant for Olesoxime in Progressive Multiple Sclerosis 10/11/2012
Addex Therapeutics (ADXN.SW) and Collaborators Awarded Swiss CTI Grant to Develop Allosteric Modulators for Neurodegenerative and Psychiatric Diseases 10/2/2012
VAXIMM Receives Grant to Expand Pipeline of Oral Cancer Vaccines 10/2/2012
ExpreS2ion Biotechnologies, Mucosis B.V., and University of Copenhagen Receive Eurostars Grant 9/25/2012
Biocitech SAS: Mutabilis Receives EUR Four Million of EU Funding for Its HIVINNOV Project 9/18/2012
CLC bio Part of $ 10M EU PATHSEEK Project 8/30/2012
Mireven Receives Further $500K From MRCF 8/27/2012
Summit Corporation Notified of Grant Award From UK Technology Strategy Board 8/2/2012
BioTime (BTX)’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.33 Million Grant From Israel’s Office of the Chief Scientist 8/1/2012
Oxford Gene Technology Ltd. Awarded €3 Million From Prestigious EU Clinical Research Grants 7/24/2012
Stem Cell Company, CellCap, Receives £75,000 Investment from The North West Fund for Biomedical 7/12/2012
GlaxoSmithKline (GSK), Novartis AG (NVS) Get U.S. Grants to Make Vaccines 6/19/2012
BrainStorm Cell Therapeutics Inc. Receives 1.3 Million NIS Grant from Israel’s Office of the Chief Scientist 6/14/2012
Government of Canada Awards CA$700,000 Toward Phase 2 Study of Edge Therapeutics's Lead Compound to Improve Outcomes After Brain Injury 6/11/2012
National Institutes of Health (NIH) Awards $6.4 Million to Professor Mark Larche to Investigate Mechanisms of Allergy Tolerance Generated by Circassia Limited's ToleroMune® Treatment 6/7/2012
Isogenica Limited, Cresset Group and Biolauncher Secure Funding from UK's Technology Strategy Board for a £1 Million Project to Develop New Small Molecule Drug Platform 6/6/2012
ERYtech Pharma Receives € 7 Million from OSEO to Lead the TEDAC Personalized Medicine Project in Cancer 6/5/2012
Telormedix, Foamix Receive EU Funding for the Development of a New Topical Skin Cancer Treatment 6/4/2012
Phagenesis Ltd Wins c. £1 million Translation Award by Wellcome Trust to Expand Dysphagia Treatment 5/22/2012
ElexoPharm Receives € 2.1 Million EUROSTARS Grant for Program Targeting Mitochondrial Diseases 5/21/2012
Innovative Cambridge Company Innova Biosciences Secures Prestigious Development of Prototype Grant from the Technology Strategy Board 5/15/2012
Medgenics, Inc. Awarded $2.2 Million Grant from the Israeli Office of the Chief Scientist 5/9/2012
€6 Million EU Grant to Consortium Lead by Prophylix Pharma AS 5/9/2012
Isogenica Limited Secures European Framework 7 Grant Worth Up to EURO 700,000 5/8/2012
Oramed Pharmaceuticals Inc. (ORMP.OB) Awarded Grant by the Office of the Chief Scientist of Israel 5/8/2012
Pluristem Therapeutics (PSTI) Awarded a $3.1 Million Grant by Israeli Government 4/30/2012
TAP Biosystems' Project to Develop a Cell Therapy for Corneal Surface Disease Receives Additional Funding for Pre-clinical and First in Man Trials 4/26/2012
Domain Therapeutics Wins EUR 933,000 Grant for Schizophrenia Project 3/13/2012
ExonHit Therapeutics Inc. is Beneficiary of a Grant from the European Union Within the Responsify Consortium 3/5/2012
Medicyte GmbH and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies 3/5/2012
Bristol-Myers Squibb Company (BMY) Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia 2/21/2012
CLC bio Part of €12M EU Grant to Uncover the Mechanisms that Determine Cell Fate 2/13/2012
Domain Therapeutics Awarded Grant from The Michael J. Fox Foundation for the Development of Novel mGluR3 PAM Compounds to Treat Parkinson's Disease 1/30/2012
Immune Pharmaceuticals Granted US$1 Million (NIS 3.8M) by the Office of the Chief Scientist in Israel 1/30/2012
Seven Young China Scientists Given $650,000 Howard Hughes Medical Institute Awards 1/26/2012
Pherecydes Pharma Secures DGA Funding for Evaluating the Use of Bacteriophages Against Infected, Antibiotic Resistant Burns 1/18/2012
Cell Medica and UCL Institute of Child Health Receive Grant Funding from UK Technology Strategy Board for Paediatric Cell Therapy Study 1/10/2012
Apogenix Receives Additional €2.3 Million BMBF Grant as Partner of the Biotech Cluster Rhine-Neckar 1/9/2012
US-China Pharmaceutical Venture Ascletis, Inc. Receives Record-Level Research and Development Grant from Hangzhou 1/4/2012
Vivo Ventures Closes $375 Million US-China Life Science Fund 1/3/2012
Foundation Fighting Blindness Announces $1.8 Million Grant to Leading Netherlands Institute, Expands International Research Portfolio 12/29/2011
TiGenix Obtains EUR 2.9 Million FP7 Grant to Fund Development of Cx611 in Rheumatoid Arthritis 12/28/2011
Trevena, Inc. Receives Research Funding for Parkinson’s Disease from The Michael J. Fox Foundation 12/19/2011
To-BBB technologies BV Receives International Innovation Grant to Support Partnership With Top-5 Pharma Company 12/19/2011
ProtAffin AG Receives Key Grant for Preclinical and Clinical Development of PA401 in Inflammatory Lung Disease 12/14/2011
Plasticell Wins Further Technology Strategy Board Funding for £1.5 Million Stem Cell Manufacturing Project 12/13/2011
Cytoo, Cenix BioScience GmbH and Academic Collaborators Bioquant, EPFL and FTMC Receive a 4 Million€ EU FP7 Grant to Launch MEHTRICS Consortium 12/12/2011
Cellzome AG Awarded UK's Technology Strategy Board Grant as Part of the Regenerative Medicine Program 12/6/2011
Orexo AB and Uppsala Universitet Receive Swedish Research Council Grant for Bioceramics Project 11/30/2011
Moberg Derma is Granted MSEK 4 for Limtop 11/15/2011
InSCREENeX Secures Grant to Develop Liver Cells with Tissue-like Characteristics 11/11/2011
Domainex Ltd Awarded Technology Strategy Board Funding to Support its Research into a Novel Cancer Drug 11/2/2011
Australian Federal Government Funds Study Into Neuroprotective Benefits of PRANA Biotechnology (PRAN)'s PBT2 10/27/2011
PRANA Biotechnology (PRAN) Release: Australian Federal Government Grant to Study Effect of PBT2 in the Aging Brain 10/21/2011
Arsanis, Inc. Receives Grant from the Austrian Research Promotion Agency for Pre-Clinical and Clinical Development of Monoclonal Antibodies Against Severe Nosocomial Infections 10/19/2011
The Michael J. Fox Foundation Awards AFFiRiS AG $1.5 Million for the Clinical Development of the First Parkinson's Disease Vaccine 10/12/2011
NeuroVive Pharmaceutical AB and To-BBB technologies BV Awarded Eurostars Grant for Development of Stroke Therapy 9/29/2011
BrainStorm Cell Therapeutics Inc. Receives Grant from Israel’s Office of the Chief Scientist 9/26/2011
Diamyd Medical AB Awarded Three Million Dollar Grant and Expands the NTTDS Portfolio 9/12/2011
Theralpha Receives Major Grant for Pain Drug Development 9/6/2011
Crossbeta Biosciences B.V. Receives Eurotrans-Bio Grant of Eur 0.75 Million 8/29/2011
Oxford Nanopore Technologies Congratulates Collaborator Professor Mark Akeson on $3.6 Million National Human Genome Research Institute Grant 8/23/2011
GlaxoSmithKline (GSK) Awarded Funds to Advance Dermal Treatment with Starpharma Pty Limited (SPL.AX)'s Dendrimers 8/22/2011
PRANA Biotechnology (PRAN) Receives Michael J. Fox Foundation Grant to Develop PBT434 for Parkinson's Disease 8/22/2011
Medgenics, Inc. Awarded Grant from the Israeli Office of the Chief Scientist 8/11/2011
PROLOR Biotech (PBTH)'s Long-Acting Human Growth Hormone Awarded $1.7 Million Grant 8/10/2011
Ark Therapeutics Led Consortium Wins €5.3 Million EU Framework Program 7 Grant 7/14/2011
m2p-labs Receives Grant for New Fed-Batch Screening Technology 7/11/2011
Ark Therapeutics Receives €0.6 Million Finnish Grants for Development of Lentiviral Production Platform 7/6/2011
Oxford Gene Technology Ltd. to Develop Tumour Profiling Assay to Facilitate Personalised Cancer Treatment 6/21/2011
INTEGROMICS Announces Winners of Proteomics Grant Competition 6/21/2011
TcLand Expression Will Receive 1.2 Million Euros from Oseo and ERDF to Support a Leading Project in Personalised Medicine Focused on Rheumatoid Arthritis 6/17/2011
Biota, Inc. Obtains US$2.9M National Institutes of Health (NIH) Grant for the Development of Novel Antibacterial 6/10/2011
Neovacs SA Receives a Payment of €1,448 Million from OSEO Following Achievement of the Second Key Milestone in the Tracker Project with TNF-Kinoid in Rheumatoid Arthritis 6/9/2011
TNO and European Consortium Members Receive a 1.2 Million Euro European Research Grant to Improve Drug Development for Infants 5/11/2011
ChinaBio(R) LLC and Keck Graduate Institute of Applied Life Sciences to Offer China Internships 4/8/2011
Scil Proteins GmbH Receives €700K Research Grant from Investitionsbank Sachsen Anhalt 4/7/2011
To-BBB technologies BV Obtains Government Loan of €1.2 Million for Clinical Trial in Brain Cancer 3/31/2011
Horizon Discovery Ltd. Receives $1.6M Grant Funding from EU FP7 Program and Joins the COLTHERES Consortium 3/31/2011
Zealand Pharma and Pepscan Awarded EU Grant of EUR 0.9 Million for the Joint Development of Novel Peptide Drugs 3/22/2011
Jones Lang LaSalle Donates 100 Million Yen, $1.25 Million, to Red Cross to Aid Japan Earthquake and Pacific Tsunami Relief Efforts 3/18/2011
Xention Participates in €12 Million Atrial Fibrillation Research Consortium 3/15/2011
Living Cell Technologies Ltd. Receives Funds from Pharmaceutical Investor 3/9/2011
BioAlliance Pharma Receives €2 Million in Funding for Peptide Applications of the Patented Lauriadtm Mucoadhesive Technology 3/3/2011
Galapagos NV (GLPG.BR) Receives EUR2.7 Million Grant for Antiviral Drug Discovery 2/7/2011
Quantum Genomics Corp. (NYSE Euronext Paris: MLQGC) Announced Today that EUR 1.4 Million in Funding has Been Granted by the National Research Agency (ANR) for a Collaborative Research Project Named BAPAI 2/2/2011
Exiqon A/S Announces 2011 Grant Program for MicroRNA Research 2/1/2011
Hepa Wash Awarded ZIM Grant 1/18/2011
Rosetta Genomics Ltd. (ROSG) Receives Grant and Joins Rimonim Pharmaceutical Consortium 1/10/2011
ExonHit Therapeutics Inc. Awarded Two Discovery Grants by the US Federal Government 12/20/2010
The Michael J. Fox Foundation Funds AFFiRiS AG to Develop Parkinson's Vaccine 12/16/2010
Trophos to lead New MitoCare Consortium Awarded EUR 6 Million by EU for POC Study of Novel Cardioprotective Compound, TRO40303 12/14/2010
Hybrigenics Receives EUR 800,000 Payment from Oseo 12/2/2010
AiCuris Gained Bio.NRW Research Promotion 11/29/2010
NEUROKIN Receives Support from ANR on its STROKININ Project 11/29/2010
Jiangsu Wuzhong Receives $1.8 Million to Develop Cancer Drug 11/29/2010
OSEO Awards a €10.4 Million Funding Package to PHARNEXT, BioSystems International, Bordeaux Hospital (CMRR1), University Bordeaux Segalen and INSERM 11/18/2010
ProtAffin Biotechnologie AG Receives Grant from FFG for Preclinical Development of PA401 in COPD 11/15/2010
Deinove's Antibiotics Project Receives €1.35 Million from OSEO Innovation, the Languedoc-Roussillon Regional Council, the French Government's Interministerial Fund and the European Regional Development Fund 11/15/2010
Amakem Receives 1.28M€ Government Funding for COPD Drug Development Program 11/15/2010
Mesoblast Limited: U.S. Government Grants Awarded for Further Development of Adult Stem Cell Products 11/8/2010
Agennix AG Awarded Approximately $490,000 Under U.S. Qualifying Therapeutic Discovery Project Grant Program 11/5/2010
Core Dynamics (USA), Inc. Announces That It Has Received a Grant from the US Army for the Development of a Freeze Dried Blood Unit 10/6/2010
DBV Technologies Granted US Patents for Allergen Delivery System VIASKIN(R) 9/24/2010
TiGenix Awarded New Grant for Biomaterials Platform Development 9/20/2010
Deinove Receives K€ 1401 From Oseo 9/17/2010
Neovacs SA Receives A Payment Of 963 K€ From OSEO for the "Tracker" Project In Rheumatoid Arthritis 9/13/2010
Addex Pharmaceuticals (ADXN.SW) Awarded Michael J. Fox Foundation Grant for ADX48621 to treat Levodopa-Induced Dyskinesia in Parkinson's Disease 9/8/2010
Addex Pharmaceuticals (ADXN.SW) Awarded Michael J. Fox Foundation Grant for ADX48621 to Treat Levodopa-Induced Dyskinesia in Parkinson's Disease 9/8/2010
Horizon Discovery Ltd. Announces that it has Been Awarded €300,000 Grant Under EUFP7 Program 8/12/2010



//-->